Engineered nanoparticles for imaging and targeted drug delivery in hepatocellular carcinoma
Abstract Liver cancer, notably hepatocellular carcinoma (HCC), poses a significant global health burden due to its high fatality rates. Conventional antitumor medications face challenges, including poor targeting, high toxicity, and drug resistance, leading to suboptimal clinical outcomes. This revi...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMC
2025-04-01
|
| Sarja: | Experimental Hematology & Oncology |
| Aiheet: | |
| Linkit: | https://doi.org/10.1186/s40164-025-00658-z |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|